A detailed history of Castleview Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Castleview Partners, LLC holds 2,252 shares of MRK stock, worth $220,808. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,252
Previous 1,843 22.19%
Holding current value
$220,808
Previous $209,000 22.01%
% of portfolio
0.18%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$111.15 - $128.97 $45,460 - $52,748
409 Added 22.19%
2,252 $255,000
Q2 2024

Jul 31, 2024

BUY
$123.8 - $132.96 $39,616 - $42,547
320 Added 21.01%
1,843 $228,000
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $39,067 - $45,522
345 Added 29.29%
1,523 $200,000
Q4 2023

Feb 05, 2024

BUY
$100.18 - $109.02 $19,034 - $20,713
190 Added 19.23%
1,178 $128,000
Q3 2023

Oct 26, 2023

SELL
$102.95 - $114.33 $4,118 - $4,573
-40 Reduced 3.89%
988 $101,000
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $202,883 - $221,133
-1,868 Reduced 64.5%
1,028 $118,000
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $4,426 - $4,938
-43 Reduced 1.46%
2,896 $308,000
Q4 2022

Feb 01, 2023

SELL
$87.44 - $112.11 $69,777 - $89,463
-798 Reduced 21.35%
2,939 $326,000
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $320,368 - $359,898
-3,790 Reduced 50.35%
3,737 $322,000
Q2 2022

Aug 17, 2022

SELL
$83.49 - $94.64 $40.3 Million - $45.7 Million
-482,785 Reduced 98.46%
7,527 $686,000
Q2 2022

Aug 16, 2022

BUY
$83.49 - $94.64 $40.2 Million - $45.5 Million
481,222 Added 5293.97%
490,312 $44.7 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $50.6 Million - $56.7 Million
-688,180 Reduced 98.7%
9,090 $745,000
Q4 2021

Feb 17, 2022

BUY
$72.28 - $90.54 $50.3 Million - $63 Million
695,808 Added 47592.89%
697,270 $53.4 Million
Q2 2021

Aug 17, 2021

BUY
$70.31 - $77.77 $102,793 - $113,699
1,462 New
1,462 $114,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.